GB2103614B - Benzazepin-2-ones - Google Patents

Benzazepin-2-ones

Info

Publication number
GB2103614B
GB2103614B GB08222564A GB8222564A GB2103614B GB 2103614 B GB2103614 B GB 2103614B GB 08222564 A GB08222564 A GB 08222564A GB 8222564 A GB8222564 A GB 8222564A GB 2103614 B GB2103614 B GB 2103614B
Authority
GB
United Kingdom
Prior art keywords
benzazepin
ones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08222564A
Other languages
English (en)
Other versions
GB2103614A (en
Inventor
Jeffrey William Herber Watthey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of GB2103614A publication Critical patent/GB2103614A/en
Application granted granted Critical
Publication of GB2103614B publication Critical patent/GB2103614B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB08222564A 1981-08-11 1982-08-05 Benzazepin-2-ones Expired GB2103614B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29190781A 1981-08-11 1981-08-11
US31986381A 1981-11-09 1981-11-09

Publications (2)

Publication Number Publication Date
GB2103614A GB2103614A (en) 1983-02-23
GB2103614B true GB2103614B (en) 1984-11-21

Family

ID=26967047

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08222564A Expired GB2103614B (en) 1981-08-11 1982-08-05 Benzazepin-2-ones

Country Status (22)

Country Link
EP (1) EP0072352B1 (enExample)
KR (3) KR890003425B1 (enExample)
AR (3) AR240806A1 (enExample)
AT (1) ATE18397T1 (enExample)
AU (1) AU561395B2 (enExample)
CA (1) CA1196636A (enExample)
CY (1) CY1403A (enExample)
DD (1) DD202546A5 (enExample)
DE (1) DE3269625D1 (enExample)
DK (1) DK157881C (enExample)
ES (6) ES8502974A1 (enExample)
FI (1) FI76074C (enExample)
GB (1) GB2103614B (enExample)
GR (1) GR77256B (enExample)
HK (1) HK93387A (enExample)
HU (1) HU189628B (enExample)
IE (1) IE53668B1 (enExample)
IL (1) IL66501A (enExample)
NL (1) NL930112I2 (enExample)
NO (1) NO161558C (enExample)
NZ (1) NZ201555A (enExample)
PT (1) PT75395B (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3242599A1 (de) * 1982-11-18 1984-05-24 Dr. Karl Thomae Gmbh, 7950 Biberach Neue benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel
US4473575A (en) * 1982-07-19 1984-09-25 Ciba-Geigy Corporation 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
EP0107095B1 (en) * 1982-09-30 1987-09-09 Merck & Co. Inc. 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents
US4575503A (en) * 1983-02-10 1986-03-11 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4564612A (en) * 1983-04-22 1986-01-14 Takeda Chemical Industries, Ltd. Condensed, seven-membered ring compounds and their use
US4539150A (en) * 1983-06-29 1985-09-03 Mitsui Toatsu Chemicals, Inc. Benzothiazepine derivatives and their methods of preparation
JPS608284A (ja) * 1983-06-29 1985-01-17 Mitsui Toatsu Chem Inc ベンゾチアゼピン誘導体およびその製造法
US4638000A (en) * 1983-08-12 1987-01-20 Takeda Chemical Industries, Ltd. Condensed seven-membered ring compounds, their production and use
AU570710B2 (en) * 1983-08-12 1988-03-24 Takeda Chemical Industries Ltd. 4-oxo-2, 3, 4, 5-tetrahydro-1, 5-benzoxazepine derivatives
IL72523A (en) * 1983-08-12 1988-06-30 Takeda Chemical Industries Ltd 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives,their production and pharmaceutical compositions containing them
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
DE3586445T2 (de) * 1984-06-26 1993-01-14 Merck & Co Inc Kondensierte benzo-laktam-verbindungen und deren pharmazeutische zusammensetzungen.
CA1266647A (en) * 1984-06-26 1990-03-13 William H. Parsons Benzofused lactams useful as antihypertensive agents and as cholecystokinin antagonists
US4785089A (en) * 1985-06-13 1988-11-15 Ciba-Geigy Corporation Novel sulfonic acid esters and their preparation
DE3704661A1 (de) * 1987-02-14 1988-08-25 Hoechst Ag Annelierte azepinon- und azocinon-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung, sowie zwischenprodukte bei ihrer herstellung
EP0322779A3 (en) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolactam compounds and pharmaceutical uses thereof
TW197945B (enExample) * 1990-11-27 1993-01-11 Hoechst Ag
GB9100028D0 (en) * 1991-01-02 1991-02-20 Ici Plc Compounds
GB9212308D0 (en) * 1992-06-10 1992-07-22 Ici Plc Therapeutic compositions
US5504080A (en) * 1992-10-28 1996-04-02 Bristol-Myers Squibb Co. Benzo-fused lactams
US5610153A (en) * 1992-12-11 1997-03-11 Ciba-Geigy Corporation Benzazepinone derivatives
GB9310075D0 (en) * 1993-05-17 1993-06-30 Fujisawa Pharmaceutical Co New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
US5801168A (en) * 1994-06-09 1998-09-01 Zeneca Limited Substituted nitrogen heterocycles
US5597922A (en) * 1994-07-29 1997-01-28 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Glycine receptor antagonist pharmacophore
MXPA02005070A (es) * 1999-11-18 2003-09-25 Antexpharma Inc 1-benzazepinas sustituidas y derivados de las mismas.
US7053211B2 (en) 2000-12-27 2006-05-30 Merck Patent Gmbh Process for the preparation of α-aminosubstituted carboxylic acid amides
BR0208513A (pt) 2001-03-27 2004-10-26 Ranbaxy Lab Ltd Processo de preparação de benazepril
US6984645B2 (en) 2001-11-16 2006-01-10 Bristol-Myers Squibb Company Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
WO2004013105A1 (en) * 2002-07-26 2004-02-12 Ciba Specialty Chemicals Holging Inc. Crystalline polymorphic and amorphous forms of benazepril hydrochloride
KR100710548B1 (ko) * 2002-12-26 2007-04-24 에스케이 주식회사 (ｓ)-3-아미노-2,3,4,5-테트라히드로-2-옥소-1Ｈ-1-벤자제핀-1-아세트산 및 이의 에스테르 화합물의 제조방법
US7459474B2 (en) 2003-06-11 2008-12-02 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8080579B2 (en) 2005-10-03 2011-12-20 The Regents Of The University Of Michigan Compositions and methods for treatment of inflammatory bowel disease
US7592461B2 (en) 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
EP2099767A1 (en) 2006-11-01 2009-09-16 Brystol-Myers Squibb Company Modulators of glucocorticoid receptor, ap-1, and/or nf- b activity and use thereof
US7968577B2 (en) 2006-11-01 2011-06-28 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
JP5546451B2 (ja) 2007-06-04 2014-07-09 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7828840B2 (en) 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
EP2334671A1 (en) 2008-06-24 2011-06-22 Bristol-Myers Squibb Company Cyclopentathiophene modulators of the glucocorticoid receptor, ap-1, and/or nf-kappa b activity and use thereof
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
HK1220696A1 (zh) 2013-03-15 2017-05-12 Bausch Health Ireland Limited 鸟苷酸环化酶激动剂及其用途
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
EP4424697A3 (en) 2013-06-05 2024-12-25 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
WO2015027021A1 (en) 2013-08-22 2015-02-26 Bristol-Myers Squibb Company Imide and acylurea derivatives as modulators of the glucocorticoid receptor
CN113292495B (zh) * 2021-06-18 2022-09-13 迪嘉药业集团有限公司 一种 (s)-氨基化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395150A (en) * 1965-02-26 1968-07-30 Squibb & Sons Inc Benzothiazepine carboxamides and derivatives thereof
GB1305278A (enExample) * 1970-03-12 1973-01-31

Also Published As

Publication number Publication date
AU561395B2 (en) 1987-05-07
IE821929L (en) 1983-02-11
ES8504728A1 (es) 1985-04-16
EP0072352B1 (de) 1986-03-05
ES8604523A1 (es) 1986-02-01
ES530658A0 (es) 1985-12-01
AR240806A2 (es) 1991-02-28
NL930112I1 (nl) 1993-10-18
IE53668B1 (en) 1989-01-04
IL66501A (en) 1987-10-20
CA1196636A (en) 1985-11-12
AU8701482A (en) 1983-05-12
ATE18397T1 (de) 1986-03-15
EP0072352A1 (de) 1983-02-16
FI76074C (fi) 1988-09-09
ES514856A0 (es) 1985-02-01
KR900001190B1 (ko) 1990-02-28
IL66501A0 (en) 1982-12-31
ES8602682A1 (es) 1985-12-01
DK157881C (da) 1990-07-23
HK93387A (en) 1987-12-18
AR241222A1 (es) 1992-02-28
FI76074B (fi) 1988-05-31
ES8606285A1 (es) 1986-04-16
DK358682A (da) 1983-02-12
NL930112I2 (nl) 1996-11-01
DD202546A5 (de) 1983-09-21
FI822770L (fi) 1983-02-12
FI822770A0 (fi) 1982-08-09
GB2103614A (en) 1983-02-23
KR840001139A (ko) 1984-03-28
NO822722L (no) 1983-02-14
CY1403A (en) 1987-12-18
ES526889A0 (es) 1986-02-01
ES526887A0 (es) 1986-04-16
ES8502974A1 (es) 1985-02-01
AR240806A1 (es) 1991-02-28
ES526886A0 (es) 1985-11-01
KR900001191B1 (ko) 1990-02-28
DE3269625D1 (en) 1986-04-10
DK157881B (da) 1990-02-26
KR890003425B1 (ko) 1989-09-20
HU189628B (en) 1986-07-28
AR240807A1 (es) 1991-02-28
NO161558B (no) 1989-05-22
PT75395A (en) 1982-09-01
NZ201555A (en) 1986-06-11
ES526888A0 (es) 1985-04-16
GR77256B (enExample) 1984-09-11
AR240807A2 (es) 1991-02-28
NO161558C (no) 1989-08-30
PT75395B (en) 1985-11-15
ES8601142A1 (es) 1985-11-01

Similar Documents

Publication Publication Date Title
GB2107733B (en) Phenylethanes
GB8317373D0 (en) Spin-on-filter
ZA823161B (en) Plunging-capsule
ZA825719B (en) Alkanoylanilides
CS404882A2 (en) Zpusob vytvareni iontu kovu
DE3273461D1 (en) 2-arylimidazopyridines
CS425382A2 (en) Zpusob vyroby derivatu chinolinu
ZA821122B (en) Imidazodiazepines
GB2106615B (en) Beertap
JPS57173348A (en) Vibator
ZA826612B (en) N-alkoxysulfenylcarbamates
ZA822490B (en) 1-substituted-4-phenyl-polyhydro-pyridines and -pyrrolidines
ZA821337B (en) 11a-amino-3 -hydroxy-androstanes
JPS57212078A (en) Printing-head
GB2107169B (en) Bootshaper
CS547782A2 (en) Sterac celniho skla
CS713582A1 (en) Zehlici zarizeni
GB8304003D0 (en) Morfoplasty
CS34682A1 (en) Zpusob vyroby reagencniho papiru
IL64656A0 (en) Chopper-mixer
GB2111489B (en) N-isopropyl-noratropine-n-oxide
CA48858S (en) Bobbypin
CS537781A1 (en) Slnecny kolektor
CS685581A1 (en) Nosic kelimkov
CS992581A1 (en) Zapojenie zdrojovej sustavy

Legal Events

Date Code Title Description
CTFF Supplementary protection certificate filed

Free format text: SPC/GB96/001, 960111

CTFG Supplementary protection certificate granted

Free format text: SPC/GB96/001, 960517, EXPIRES:20050628

732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PE20 Patent expired after termination of 20 years

Effective date: 20020804

CTFE Supplementary protection certificate entered into force

Free format text: SPC/GB96/001: 20020805, EXPIRES: 20050628

SPCE Supplementary protection certificate expired

Free format text: SPC/GB96/001, EXPIRES: 20050628

Spc suppl protection certif: SPC/GB96/001

Expiry date: 20050628